PROKAI; LASZLO
Patent Applications and Registrations
Patent applications and USPTO patent grants for PROKAI; LASZLO.The latest application filed is for "reconstituted hdl nanoparticles for delivery of radioactive agents and uses thereof".
- PROKAI; LASZLO - MANSFIELD TX
- Prokai; Laszlo - Gainesville FL
| Patent | Date |
|---|---|
| Reconstituted Hdl Nanoparticles For Delivery Of Radioactive Agents And Uses Thereof App 20220008571 - LACKO; ANDRAS G. ; et al. | 2022-01-13 |
| Marker Detection Method And Apparatus To Monitor Drug Compliance App 20140294675 - Melker; Richard J. ; et al. | 2014-10-02 |
| HDL particles for delivery of nucleic acids Grant 8,734,853 - Sood , et al. May 27, 2 | 2014-05-27 |
| HDL Particles for Delivery of Nucleic Acids App 20110312899 - Sood; Anil K. ; et al. | 2011-12-22 |
| Prodrugs for use as ophthalmic agents Grant 7,572,781 - Prokai , et al. August 11, 2 | 2009-08-11 |
| Quinol compound and pharmaceutical composition Grant 7,534,779 - Prokai , et al. May 19, 2 | 2009-05-19 |
| Systems and Methods for Evaluating Enzyme Competency App 20090005270 - Melker; Richard J. ; et al. | 2009-01-01 |
| Imaging of Neural and Organ Injury or Damage App 20080311036 - Wang; Kevin Ka-Wang ; et al. | 2008-12-18 |
| Isotope Labeled Dinitrophenylhydrazines and Methods of Use App 20080193915 - Prokai; Laszlo ; et al. | 2008-08-14 |
| Prodrugs for Use as Ophthalmic Agents App 20080119446 - Prokai; Laszlo ; et al. | 2008-05-22 |
| Steroidal quinols and their use for estrogen replacement therapy Grant 7,300,926 - Prokai , et al. November 27, 2 | 2007-11-27 |
| Drug adherence monitoring system App 20070224128 - Dennis; Donn Michael ; et al. | 2007-09-27 |
| Prodrugs for Use as Ophthalmic Agents App 20070213310 - Prokai; Laszlo ; et al. | 2007-09-13 |
| Prodrugs for use as ophthalmic agents App 20070155711 - Prokai; Laszlo ; et al. | 2007-07-05 |
| Prodrugs for use as ophthalmic agents Grant 7,186,707 - Prokai , et al. March 6, 2 | 2007-03-06 |
| Thyrotropin-releasing hormone analogues and their therapeutic applications Grant 7,067,257 - Prokai June 27, 2 | 2006-06-27 |
| Steroidal quinols and their use for antioxidant therapy Grant 7,026,306 - Prokai , et al. April 11, 2 | 2006-04-11 |
| Antagonists of RF-amide neuropeptides Grant 6,960,574 - Prokai November 1, 2 | 2005-11-01 |
| Marker detection method and apparatus to monitor drug compliance App 20050233459 - Melker, Richard J. ; et al. | 2005-10-20 |
| Antagonists of RF-amide neuropeptides Grant 6,797,707 - Prokai September 28, 2 | 2004-09-28 |
| Antagonists of RF-amide neuropeptides App 20040176340 - Prokai, Laszlo | 2004-09-09 |
| Prodrugs for use as ophthalmic agents App 20040171596 - Prokai, Laszlo ; et al. | 2004-09-02 |
| Steroidal quinols and their use for estrogen replacement therapy App 20040138190 - Prokai, Laszlo ; et al. | 2004-07-15 |
| Thyrotropin-releasing hormone analogues and their therapeutic applications App 20030232966 - Prokai, Laszlo | 2003-12-18 |
| Steroidal quinols and their use for antioxidant therapy App 20030229060 - Prokai, Laszlo ; et al. | 2003-12-11 |
| Antagonists of RF-amide neuropeptides App 20030199495 - Prokai, Laszlo | 2003-10-23 |
| Alkyl ether modified polycyclic compounds having a terminal phenol and uses for protection of cells App 20020035100 - Prokai, Laszlo ; et al. | 2002-03-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 